GSK PLC (GSK) reports robust sales growth and upgrades its full-year guidance, driven by strong performance in specialty medicines and oncology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback